October 14, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of the risk for leukopenia/neutropenia in patients receiving antipsychotics, including ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback